Concepedia

Xiaojing Shi

XS

Statistics

Publications

8

Citations

273

H-Index

8

Active since

2014

Affiliations

Jinzhou Medical University(Current)

Zhengzhou University

First Hospital of China Medical University

Ministry of Education

China Medical University

Xiaojing Shi is an author at Jinzhou Medical University specializing in pharmacology, apoptosis, and life sciences.

ORCID

Publications per year

2014–2022

8

Publications

8

Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin

Zeting Yuan, Xiaojing Shi, Yanyan Qiu et al. · Oncology Reports · 2017 · 63 citations · Full text

, , +13

<p>Sappanone A Protects Against Myocardial Ischemia Reperfusion Injury by Modulation of Nrf2</p>

Xiaojing Shi, Guizhou Tao, Lili Ji et al. · Drug Design Development and Therapy · 2020 · 46 citations · Full text

, , +17

Empagliflozin alleviates ethanol‐induced cardiomyocyte injury through inhibition of mitochondrial apoptosis via a SIRT1/PTEN/Akt pathway

Ge Tian, Yang Yu, Hanyu Deng et al. · Clinical and Experimental Pharmacology and Physiology · 2021 · 41 citations

, , +15

Pharmacological postconditioning with sappanone A ameliorates myocardial ischemia reperfusion injury and mitochondrial dysfunction via AMPK-mediated mitochondrial quality control

Xiaojing Shi, Yang Li, Yaguang Wang et al. · Toxicology and Applied Pharmacology · 2021 · 36 citations

, , +16

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning

Cheng Zhang, Mengnan Shi, Woonghee Kim et al. · EBioMedicine · 2022 · 30 citations · Full text

, , +10

1–5 of 8